Synthaverse (WAR:SVE) Piotroski F-Score: 3 (As of Jun. 28, 2026) — 40% Below Median


WAR:SVE Synthaverse SA WAR:SVE
55 GF Score
Price zł2.66
GF Value zł3.04
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Synthaverse Piotroski F-Score?

Synthaverse WAR:SVE -1.67% 55 Piotroski F-Score is 3 as of Jun. 28, 2026, which is 40% below its 10-year median of 5.00. GuruFocus rates WAR:SVE with a GF Score™ of 55/100 and a GF Value™ of zł3.04 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 1,340 Biotechnology companies, Synthaverse ranks better than 55% on this metric.

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Synthaverse has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Synthaverse's Piotroski F-Score or its related term are showing as below:

WAR:SVE' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 5   Max: 8
Current: 3

During the past 13 years, the highest Piotroski F-Score of Synthaverse was 8. The lowest was 2. And the median was 5.

Synthaverse  (WAR:SVE) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Synthaverse Piotroski F-Score Related Terms


Synthaverse Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Synthaverse's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synthaverse Piotroski F-Score Chart

Synthaverse Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 4.00 2.00 5.00 3.00

Synthaverse Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 5.00 5.00 3.00 3.00

WAR:SVE vs VRTX, REGN, ALNY: Piotroski F-Score Comparison

For the Biotechnology subindustry, Synthaverse's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Synthaverse Piotroski F-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Synthaverse's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Synthaverse's Piotroski F-Score falls into.


WAR:SVE
55GF Score
Synthaverse SA WAR:SVE
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was -4.767 + -7.725 + -6.902 + -3.606 = zł-23.00 Mil.
Cash Flow from Operations was 3.704 + -13.974 + 13.43 + 5.383 = zł8.54 Mil.
Revenue was 6.285 + 4.79 + 17.507 + 13.61 = zł42.19 Mil.
Gross Profit was 4.225 + 1.667 + 9.496 + 7.178 = zł22.57 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(298.653 + 303.264 + 304.46 + 304.131 + 297.735) / 5 = zł301.6486 Mil.
Total Assets at the begining of this year (Mar25) was zł298.65 Mil.
Long-Term Debt & Capital Lease Obligation was zł1.99 Mil.
Total Current Assets was zł117.72 Mil.
Total Current Liabilities was zł133.65 Mil.
Net Income was 1.416 + -0.444 + 6.972 + -0.538 = zł7.41 Mil.

Revenue was 15.198 + 13.408 + 29.248 + 13.429 = zł71.28 Mil.
Gross Profit was 9.43 + 8.456 + 18.96 + 8.174 = zł45.02 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(291.712 + 293.22 + 290.326 + 298.622 + 298.653) / 5 = zł294.5066 Mil.
Total Assets at the begining of last year (Mar24) was zł291.71 Mil.
Long-Term Debt & Capital Lease Obligation was zł62.17 Mil.
Total Current Assets was zł45.33 Mil.
Total Current Liabilities was zł44.07 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Synthaverse's current Net Income (TTM) was -23.00. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Synthaverse's current Cash Flow from Operations (TTM) was 8.54. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-23/298.653
=-0.07701245

ROA (Last Year)=Net Income/Total Assets (Mar24)
=7.406/291.712
=0.02538805

Synthaverse's return on assets of this year was -0.07701245. Synthaverse's return on assets of last year was 0.02538805. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Synthaverse's current Net Income (TTM) was -23.00. Synthaverse's current Cash Flow from Operations (TTM) was 8.54. ==> 8.54 > -23.00 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=1.991/301.6486
=0.0066004

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=62.166/294.5066
=0.21108525

Synthaverse's gearing of this year was 0.0066004. Synthaverse's gearing of last year was 0.21108525. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=117.717/133.653
=0.88076586

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=45.334/44.065
=1.02879837

Synthaverse's current ratio of this year was 0.88076586. Synthaverse's current ratio of last year was 1.02879837. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Synthaverse's number of shares in issue this year was 75.771. Synthaverse's number of shares in issue last year was 70.771. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=22.566/42.192
=0.53484073

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=45.02/71.283
=0.63156713

Synthaverse's gross margin of this year was 0.53484073. Synthaverse's gross margin of last year was 0.63156713. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=42.192/298.653
=0.14127432

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=71.283/291.712
=0.24436088

Synthaverse's asset turnover of this year was 0.14127432. Synthaverse's asset turnover of last year was 0.24436088. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+0+1+1+0+0+0+0
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Synthaverse has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 3 mean?
Synthaverse (WAR:SVE) has a Piotroski F-Score of 3 as of Jun. 28, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Synthaverse and its competitors. This is 40% below median its historical median of 5.00. Over the past decade, Synthaverse's Piotroski F-Score has ranged from 2.00 to 8.00. According to the industry distribution chart, Synthaverse ranks #603 out of 1340 companies in the Biotechnology industry, placing it in the top 45%.
Is Synthaverse's Piotroski F-Score too high?
Synthaverse's current Piotroski F-Score of 3 is 40% below median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 8.00. The Biotechnology industry median Piotroski F-Score is 3.00. Synthaverse's value of 3 is 0% at this industry median. Based on the distribution chart, Synthaverse ranks #603 out of 1340 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Synthaverse has a GF Score™ of 55/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Synthaverse's Piotroski F-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Synthaverse ranks #603 out of 1340 companies for Piotroski F-Score. This puts Synthaverse in the upper half of its industry. The industry median Piotroski F-Score is 3.00. Synthaverse's value of 3 is 0% at this benchmark. Historically, Synthaverse's own Piotroski F-Score has ranged from 2.00 to 8.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 3.00, Synthaverse has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Biotechnology company?
The median Piotroski F-Score among Biotechnology companies is 3.00, based on 1,340 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Synthaverse's current Piotroski F-Score of 3 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Synthaverse and its competitors. For the Biotechnology industry, the median Piotroski F-Score is 3.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synthaverse's current Piotroski F-Score is 3, which is 40% below median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synthaverse stock overvalued right now?
Based on GuruFocus' analysis, Synthaverse (WAR:SVE) is currently considered Modestly Undervalued. The stock's GF Value™ is zł3.04, compared to a current price of zł2.66 — trading 12.7% below its estimated fair value. The current Piotroski F-Score is 3, which is 40% below median its 10-year median of 5.00 and 0% at the Biotechnology industry median of 3.00. Synthaverse's overall GF Score™ is 55/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Synthaverse (WAR:SVE), the current Piotroski F-Score is 3 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Synthaverse (WAR:SVE) Overvalued in 2026?

Based on GuruFocus' analysis, Synthaverse stock appears to be undervalued. The current stock price of zł2.66 is trading 12.7% below its estimated GF Value™ of zł3.04. GuruFocus considers Synthaverse to be Modestly Undervalued.

Key valuation signals for WAR:SVE:

  • Piotroski F-Score: 3 (40% below median its 10-year median of 5.00)
  • GF Value™: zł3.04 vs. price of zł2.66 (12.7% below fair value)
  • GF Score™: 55/100 with 8 warning signs
  • Industry Position: 0% at the Biotechnology median (#603 of 1340)

No single metric tells the full story. See the WAR:SVE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Synthaverse Business Description

Other Exchanges 6NQ:Germany
Address 10, Uniwersytecka street, Lublin, POL, 20-029
Synthaverse SA is a global pharmaceutical company. Its goal is to provide the best, innovative and unique solutions for medicine. Its work is based on scientific and health knowledge. Along with its expert approach, it allows the company to create reliable and unique products. It manufactures one of the few drugs used internationally in the oncological immunotherapy of bladder cancer.
55GF Score

Get the complete analysis for WAR:SVE

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł2.66
Price
zł3.04
GF Value